Temozolomide in aggressive pituitary adenomas and carcinomas. Clinics, [S. l.], v. 67, n. supl.1, p. 119–123, 2012. DOI: 10.6061/clinics/2012(Sup01)20. Disponível em: https://journals.usp.br/clinics/article/view/19731.. Acesso em: 17 jun. 2024.